 BRYAN, Texas, Sept. 20, 2021 GLOBE NEWSWIRE -- iBio, Inc. NYSEA:IBIO iBio or the Company, a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System, announced today that it will report its fiscal fourth quarter and full year 2021 financial results before market open on Monday, September 27, 2021. iBio management will host a webcast and conference call at 8:30 a.m. Eastern Time to discuss the results and provide a corporate update. 